RxDoctor Payments Data

Nithin Adappa, MD

Otolaryngology · Philadelphia, PANPI 1356500680

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $62,100 of the $71,983 with a category attached, or 86.3%. Acclarent, Inc accounts for 78.7% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $22,304 and has fallen 88.5% since, to $2,566 in 2025. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$71,983in general payments, 2019–2025

Across 141 payments — averaging $510.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$57K
  • Optinose US, Inc.$11K
  • Integra Lifesciences Corporation$3K
  • 3-d Matrix, Inc.$1K
  • Medtronic$423
  • Aerin Medical Inc.$160
  • plus $385 from 5 others

What the payments were for

  • Consulting fees$62,10086%
  • Travel & lodging$1,8803%
  • Food & beverage$8,00311%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$71,983 in reported general payments places this provider in the 95th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$230,701
Medicare patients
291
Services billed
1,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide37$3,455
Mupirocin61$682
Azithromycin53$581
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav43$490
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim38$179
Prednisone44$167
Levofloxacin17$140
Doxycycline Hyclate11$89

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →